Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
February 14, 2025 - The FDA approved Sanofi-Aventis’ Merilog (insulin-aspart-szjj), biosimilar to Novo Nordisk’s Novolog® (insulin aspart).
Download PDF
Return to publications
